Elevate your longevity practice with aesthetics that match the medicine
Patients are no longer asking for “just Botox” or “a laser.” They want healthier, longer lives—and they want to look as good as they feel. This workshop shows you how to align facial rejuvenation, injectables, and energy‑based devices with the same longevity, hormone, and metabolic principles that drive your core practice.
In this course, you will move from anatomy and safety to real‑world treatment plans, complication management, and workflow integration—plus demos that translate directly to your next clinic day.
What you will learn
Map facial anatomy, aging pathways, and high‑risk zones so you can treat confidently and avoid serious complications in longevity patients on HRT, GLP‑1s, and complex regimens.
Build evidence‑based protocols for neuromodulators, fillers, and energy‑based devices that respect metabolic, hormonal, and skin‑type differences.
Design staged treatment plans and follow‑up workflows for real longevity patients—from perimenopausal women to male executives on TRT and GLP‑1 users with rapid facial changes.
Integrate aesthetics into your clinic flow, documentation, photography, and consent, while adding straightforward, ethical business structures that support profitability and continuity of care.
Who should register
MD, DO, NP, PA, and other licensed clinicians in longevity, hormone, metabolic, or functional medicine who want to add or upgrade aesthetic services.
Existing aesthetic providers who want to better serve complex longevity patients on hormones, GLP‑1s, and multi‑system protocols.
- How medspa/aesthetic services fit into a comprehensive longevity and metabolic optimization model.
- How trends affect a longevity HCP’s decisions, not just market overview.
- Vascular and nerve anatomy; structural changes with age; “no-go” and high-risk areas for injectable and energy-based devices.
- Focus on preventing and recognizing serious complications (ischemia, vision issues, embolic events).
- Dosing strategies, product selection, and treatment planning for midlife and older adults; special considerations with hormones, anticoagulants, GLP-1s, and comorbidities.
- Script as “longevity-typical” cases: GLP-1 patient with volume loss, peri-postmenopause face
- Keep highly educational (anatomy, dose, consent, complications)
- Indications, contraindications, and treatment sequencing for photoaging and texture laxity.
- Considerations for patients on hormone therapy, with darker skin types, or with autoimmune/metabolic disease; sample treatment algorithms.
Joseph Russo, MD | 0.75 hr
- Esthetics slot: DiamondGlow, PDGF, chemical peels, and product integration.
- How to plug these services into a medical-longevity plan (pre/post hormone balancing, mitochondrial support).
- Microchannel delivery techniques: safety, depth, and formulation considerations
- Peptides for skin repair: GHK-Cu, PTD-DBM, Matrixyl, and more
- Clinical protocols for skin laxity, melasma, and scar remodeling
- Combining microneedling, exosomes, and East-West skin philosophy
-
This is where many longevity HCPs will want practical answers:
- How to prioritize what to add first: neuromodulators vs devices vs esthetics.
- Staffing models (MD + NP + injector + esthetician).
- How to stage implementation over 6–24 months.
Joseph Russo, MD; Erika Schwartz, MD; Katie Malin | 0.5 hr